Beijing Airdoc Technology Co., Ltd. (HKG:2251)
Hong Kong · Delayed Price · Currency is HKD 12.76
+0.04 (0.31%)
Oct 27, 2025, 3:57 PM HKT
Beijing Airdoc Technology Revenue
Beijing Airdoc Technology had revenue of 83.71M CNY in the half year ending June 30, 2025, with 1.47% growth. This brings the company's revenue in the last twelve months to 146.37M, down -31.98% year-over-year. In the year 2024, Beijing Airdoc Technology had annual revenue of 156.37M, down -23.34%.
Revenue (ttm)
146.37M CNY
Revenue Growth
-31.98%
P/S Ratio
8.21
Revenue / Employee
519.04K CNY
Employees
282
Market Cap
1.32B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 156.37M | -47.60M | -23.34% |
| Dec 31, 2023 | 203.96M | 90.31M | 79.46% |
| Dec 31, 2022 | 113.66M | -1.52M | -1.32% |
| Dec 31, 2021 | 115.18M | 67.51M | 141.61% |
| Dec 31, 2020 | 47.67M | 17.26M | 56.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 35.81B |
| Sino Biopharmaceutical | 33.49B |
| Alibaba Health Information Technology | 32.81B |
| CSPC Pharmaceutical Group | 28.49B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |